SCHEMBL20208137

SCHEMBL20208137

c1cc(-c2ccc3cc(-c4c5ccccc5nc5c4ccc4cccnc45)ccc3c2)cc(-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 5/20 0.36
▸ ESR2 Q92731 4/20 0.36
▸ TOP1 P11387 6/20 0.35
▸ PDE10A Q9Y233 1/20 0.34
▸ MAPT P10636 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ ATM Q13315 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ LMNA P02545 2/20 0.33
▸ METAP2 P50579 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ GMNN O75496 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ MMP2 P08253 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ MMP9 P14780 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21308558 0.96 TOP1 (0.36) ESR1ESR2TOP1PDE10AMAPT
SCHEMBL21308990 0.96 TOP1 (0.38) ESR1ESR2TOP1PDE10AMAPT
SCHEMBL20208142 0.95 PDE10A (0.39) ESR1ESR2TOP1PDE10AMAPT
SCHEMBL21308554 0.95 PDE10A (0.39) ESR1ESR2TOP1PDE10AMAPT
SCHEMBL20208140 0.94 TOP1 (0.36) ESR1ESR2TOP1PDE10AMAPT
SCHEMBL20207904 0.93 KDM4E (0.38) ESR1ESR2TOP1MAPTKDM4E
SCHEMBL20207912 0.92 KDM4E (0.37) ESR1ESR2TOP1MAPTKDM4E
SCHEMBL21308695 0.91 KDM4E (0.36) ESR1ESR2TOP1MAPTKDM4E
SCHEMBL21308991 0.89 L3MBTL1 (0.40) ESR1ESR2TOP1MAPTKDM4E
SCHEMBL21309023 0.89 TOP1 (0.36) ESR1ESR2TOP1PDE10AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11248008-B2 Heterocyclic compound and organic light emitting element using same LT MATERIALS CO., LTD. (KR) 2022-02-15 — — US disclosed
US-20190263834-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2019-08-29 — — US disclosed
WO-2018097648-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME 희성소재(주) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190263834-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME CRY1, CRY2, CYP1A1 ESR1 223/4885ESR2 622/4885TOP1 839/4885
US-11248008-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, CYP1A1 ESR1 223/4885ESR2 622/4885TOP1 839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback